Haaparanta M - Search Results

1

Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.

Blomqvist G, Stone-Elander S, Halldin C, Roland PE, Swahn CG, Haaparanta M, Solin O, Lindqvist M, Widén L. Blomqvist G, et al. Among authors: haaparanta m. Acta Radiol Suppl. 1991;376:171-2. Acta Radiol Suppl. 1991. PMID: 1666769 No abstract available.

2

Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomography.

Blomqvist G, Seitz RJ, Sjögren I, Halldin C, Stone-Elander S, Widén L, Solin O, Haaparanta M. Blomqvist G, et al. Among authors: haaparanta m. Acta Physiol Scand. 1994 May;151(1):29-43. doi: 10.1111/j.1748-1716.1994.tb09718.x. Acta Physiol Scand. 1994. PMID: 8048334

3

Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.

Laihinen A, Rinne JO, Någren K, Bergman J, Haaparanta M, Solin O, Ruotsalainen U, Rinne UK. Laihinen A, et al. Among authors: haaparanta m. Acta Radiol Suppl. 1991;376:151. Acta Radiol Suppl. 1991. PMID: 1666759 No abstract available.

4

Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson's disease.

Rinne JO, Laihinen A, Någren K, Bergman J, Haaparanta M, Solin O, Ruotsalainen U, Rinne UK. Rinne JO, et al. Among authors: haaparanta m. Acta Radiol Suppl. 1991;376:152. Acta Radiol Suppl. 1991. PMID: 1666760 No abstract available.

5

Striatal kinetics of [11C]-(+)-nomifensine and 6-[18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography.

Tedroff J, Aquilonius SM, Laihinen A, Rinne U, Hartvig P, Anderson J, Lundqvist H, Haaparanta M, Solin O, Antoni G, et al. Tedroff J, et al. Among authors: haaparanta m. Acta Neurol Scand. 1990 Jan;81(1):24-30. doi: 10.1111/j.1600-0404.1990.tb00926.x. Acta Neurol Scand. 1990. PMID: 2330812

6

Comparative double-tracer whole-body autoradiography: uptake of 11C-, 18F- and 3H-labeled compounds in rat tumors.

d'Argy R, Paul R, Frankenberg L, Stålnacke CG, Lundqvist H, Kangas L, Halldin C, Någren K, Roeda D, Haaparanta M, et al. d'Argy R, et al. Among authors: haaparanta m. Int J Rad Appl Instrum B. 1988;15(5):577-85. doi: 10.1016/s0969-8051(88)80018-0. Int J Rad Appl Instrum B. 1988. PMID: 2978293

7

Scintigraphy with [18F]2-fluoro-2-deoxy-D-glucose of cancer patients.

Paul R, Roeda D, Johansson R, Ahonen A, Haaparanta M, Solin O, Sipilä H. Paul R, et al. Among authors: haaparanta m. Int J Rad Appl Instrum B. 1986;13(1):7-12. doi: 10.1016/0883-2897(86)90245-x. Int J Rad Appl Instrum B. 1986. PMID: 3771240

8

Imaging of rats with mammary cancer with two 2-deoxy-2-[18F]fluoro-D-hexoses.

Paul R, Aho K, Bergman J, Haaparanta M, Kulmala J, Reissell A, Solin O. Paul R, et al. Among authors: haaparanta m. Int J Rad Appl Instrum B. 1989;16(5):449-53. doi: 10.1016/0883-2897(89)90054-8. Int J Rad Appl Instrum B. 1989. PMID: 2509402

9

Organ and tumor distribution of (18F)-2-fluoro-2-deoxy-D-glucose in fasting and non-fasting rats.

Paul R, Kiuru A, Söderström KO, Tuominen J, Johansson R, Haaparanta M, Roeda D, Solin O. Paul R, et al. Among authors: haaparanta m. Life Sci. 1987 Apr 20;40(16):1609-16. doi: 10.1016/0024-3205(87)90127-5. Life Sci. 1987. PMID: 3031405

10

Pharmacokinetics and metabolism of 2-[18F]fluoro-2-deoxy-D-glucose (FDG) in mammary tumors of antiestrogen-treated rats.

Haaparanta M, Paul R, Huovinen R, Kujari H, Bergman J, Solin O, Kangas L. Haaparanta M, et al. Nucl Med Biol. 1995 May;22(4):483-9. doi: 10.1016/0969-8051(94)00121-y. Nucl Med Biol. 1995. PMID: 7550025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters